-
Accelerated Access Pathways at Canada’s Drug Agency: Evaluating Progress and Future Directions in HTA
Mar 27, 2025, 21:39 PM -
How to Use Real-world Data Across Regions to Gain Regulatory Approval: A Case Study
Mar 27, 2025, 21:39 PM -
Requirements for Patient-Reported Outcome and Data Analytics in Health Technology Assessment in England, France and Germany, and Opportunities for Methods Harmonization across European Markets
Mar 27, 2025, 21:39 PM -
From Research to Policy: Incorporating Patient Preferences for Colorectal Cancer Treatments Into Health Technology Assessment
Mar 27, 2025, 21:39 PM -
Economic Burden of Recurrence among Patients with High-Risk Non-Muscle-Invasive Bladder Cancer who Received Bacillus Calmette-Guérin in the United States: A SEER-Medicare Study
Mar 27, 2025, 21:39 PM -
Healthcare Resource Utilization (HCRU) and Cost among Patients with Metastatic Melanoma Receiving Nivolumab + Relatlimab (NIVO+RELA) or Nivolumab + Ipilimumab (NIVO+IPI) in the Optum Database
Mar 27, 2025, 21:39 PM -
Long Term Healthcare Costs and Utilization Among Patients with Non Obstructive Hypertrophic Cardiomyopathy
Mar 27, 2025, 21:39 PM -
Inclusion of Health-Related Quality of Life (HRQoL) and Other Patient-Reported Outcomes (PROs) in Reimbursement Reviews From the Canadian Agency for Drugs and Technologies in Health (CADTH)
Mar 27, 2025, 21:39 PM -
Impact of Individualized Neoantigen Therapies on Health, Productivity and Health System Capacity Outcomes in Resectable Melanoma in England
Mar 10, 2025, 14:00 PM -
Access and Quality of Usual Source of Care and Racial/Ethnic Disparities in US Adults with Multiple Chronic Conditions
Mar 10, 2025, 14:00 PM -
Comparison of Demographics and Clinical Characteristics Using Real World Data from Tempus Multimodal Database and SEER Cancer Registry Across 17 Solid Cancer Cohorts
Mar 10, 2025, 14:00 PM -
Computer-Assisted Fluoroscopic Navigation Is Cost Effective Compared To Robotic-Assisted And Manual Surgery In Total Hip Arthroplasty
Mar 10, 2025, 14:00 PM -
The Contribution of Lab Results Data Linked to Claims Data in Identifying Chronic Kidney Disease Staging
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization And Costs Following Disease Progression With First-Line Systemic Therapy In Patients With Advanced Endometrial Cancer in the US
Mar 10, 2025, 14:00 PM -
Beyond Clinical Data: Assessing Usage Patterns of Real-World Home-Reported Outcomes To Capture the Full Burden of Atopic Dermatitis Symptoms and Flares
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Mineralocorticoid Receptor Antagonists in Heart Failure With Reduced Ejection Fraction: The Brazilian Case With Bayesian Networks and Markov Influence Diagrams
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization for Medicare Patients with Non-Cystic Fibrosis Bronchiectasis (NCFB) and Exacerbations Coinfected with Pseudomonas aeruginosa
Mar 10, 2025, 14:00 PM -
Patient, Caregiver, and Physician Perspectives on the Burden of Disease Chronic Refractory Gout and Its Treatment: Concept Elicitation
Mar 10, 2025, 14:00 PM -
The Impact of Caring for Juvenile Idiopathic Arthritis Patients on Caregivers’ Quality of Life
Mar 10, 2025, 14:00 PM -
The Association Between COVID-19 Vaccination History and the Incidence of COVID-19 and Healthcare Resource Use in Rural Residents in Japan
Mar 10, 2025, 14:00 PM
